Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients

por Zecca, Chiara, Yawalkar, Nikhil, Gobbi, Claudio
Publicado 2012

Life-threatening asthma attack during prolonged fingolimod treatment: case report

por Zecca, Chiara, Caporro, Matteo, Györik, Sandor, Gobbi, Claudio
Publicado 2014

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple scle...

por Caporro, Matteo, Disanto, Giulio, Gobbi, Claudio, Zecca, Chiara
Publicado 2014

Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection—a case report

por Zecca, Chiara, Mainetti, Carlo, Blum, Roland, Gobbi, Claudio
Publicado 2015

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

por Zecca, Chiara, Disanto, Giulio, Mühl, Sarah, Gobbi, Claudio
Publicado 2017

Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosi...

por Eisler, Jennifer Jessica, Disanto, Giulio, Sacco, Rosaria, Zecca, Chiara, Gobbi, Claudio
Publicado 2023

Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

por Zecca, Chiara, Disanto, Giulio, Sacco, Rosaria, Riccitelli, Gianna C., Gobbi, Claudio
Publicado 2019

Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland

por Scotti, Barbara, Disanto, Giulio, Sacco, Rosaria, Guigli, Marilu’, Zecca, Chiara, Gobbi, Claudio
Publicado 2018

A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation

por Colucci, Giuseppe, Pabst, Thomas, Bacher, Ulrike, Maggioli, Caterina, Zecca, Chiara, Gobbi, Claudio
Publicado 2020

SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting

por Zecca, Chiara, Czaplinski, Adam, Henny, Christophe, Petrini, Liliane, Beeler, Andreas, Gobbi, Claudio
Publicado 2020

Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain Processing

por Pravatà, Emanuele, Riccitelli, Gianna C., Sestieri, Carlo, Sacco, Rosaria, Cianfoni, Alessandro, Gobbi, Claudio, Zecca, Chiara
Publicado 2021

Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping

por Sparasci, Davide, Gobbi, Claudio, Castelnovo, Anna, Riccitelli, Gianna Carla, Disanto, Giulio, Zecca, Chiara, Manconi, Mauro
Publicado 2022

Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial

por Gobbi, Claudio, Meier, Dominik S, Cotton, François, Sintzel, Martina, Leppert, David, Guttmann, Charles R G, Zecca, Chiara
Publicado 2013

Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta

por Zecca, Chiara, Riccitelli, Gianna C, Calabrese, Pasquale, Pravatà, Emanuele, Candrian, Ursula, Guttmann, Charles RG, Gobbi, Claudio
Publicado 2014

Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study

por Zecca, Chiara, Disanto, Giulio, Sacco, Rosaria, MacLachlan, Sharon, Kuhle, Jens, Ramagopalan, Sreeram V., Gobbi, Claudio
Publicado 2020

Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS)

por Tsivgoulis, Georgios, Deftereos, Spyros, Gobbi, Claudio, Gulowsen Celius, Elisabeth, Kulakowska, Alina, Maniscalco, Giorgia, Mendes, Irene, Grigoriadis, Nicolaos
Publicado 2022

Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study

por Gantenbein, Andreas R, Agosti, Reto, Gobbi, Claudio, Flügel, Dominique, Schankin, Christoph J, Viceic, Dragana, Zecca, Chiara, Pohl, Heiko
Publicado 2021

Awareness of headache and of national headache society activities among primary care physicians – a qualitative study

por Gantenbein, Andreas R, Jäggi, Christian, Sturzenegger, Mathias, Gobbi, Claudio, Merki-Feld, Gabriele S, Emmenegger, Mark J, Taub, Ethan, Sándor, Peter S
Publicado 2013

Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis

por Ostini, Camilla, Bovis, Francesca, Disanto, Giulio, Ripellino, Paolo, Pravatà, Emanuele, Sacco, Rosaria, Padlina, Giovanna, Sormani, Maria Pia, Gobbi, Claudio, Zecca, Chiara
Publicado 2021

Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters

por Riccitelli, Gianna C., Disanto, Giulio, Sacco, Rosaria, Sparasci, Davide, Sacco, Leonardo, Castelnovo, Anna, Miano, Silvia, Manconi, Mauro, Gobbi, Claudio, Zecca, Chiara
Publicado 2021